The Role of Nurses in the Management of Psychotic Symptoms
DOI:
https://doi.org/10.5538/2385-703X.2026.31.29Abstract
Objectives: To examine the role of nurses in the management of psychotic symptoms.
Materials and methods: A comprehensive literature review of primary and secondary sources was conducted between February and April 2021. PubMed, Scopus, LILACS, and CUIDEN were searched, and documents published in English, Spanish, and Portuguese were selected.
Results: The identification of psychotic symptoms is based on observing behavioural signs such as talking to oneself or unprovoked laughter, among others. Several assessment methods are available, with the clinical interview being particularly important. The interventions associated with the best long-term outcomes are combined approaches involving antipsychotic medication, psychological treatment, nursing care, and psychoeducation. Nursing management begins with the establishment of a strong therapeutic relationship, which usually requires more time than usual. Psychosocial care is based mainly on behaviour modification techniques and aims to improve functioning, well-being, and quality of life.
Discussion: Psychotic symptoms occur in a range of mental disorders and medical conditions and affect both patients and their families. Nursing interventions should be comprehensive, combining pharmacological and psychological therapies while prioritising patient well-being. Behaviour modification strategies are particularly useful for negative symptoms and require an interdisciplinary approach.
Recommendations: Nurses play a fundamental role in the management of psychotic symptoms, as they are central members of the multidisciplinary team.
Keywords: psychotic symptoms, psychosis, nursing care.
References
1. Calabrese J, Al Khalili Y. Psychosis. 2023. En: StatPearls [Internet]. Treasure Island: StatPearls Publishing; 2025. Disponible en: https://www.ncbi.nlm.nih.gov/books/ NBK546579/
2. American Psychiatric Association (APA). Schizophrenia spectrum and other psychotic disorders. En: APA. Diag-nostic and Statistical Manual of Mental Disorders (DSM-5).
5.ª ed. Washington D.C.: APA; 2013.
3. Waters F, Fernyhough C. Hallucinations: a systematic re-view of points of similarity and difference across diagnos-tic classes. Schizophr Bull. 2017;43(1):32-43.
4. Organización Mundial de la Salud (OMS). Esquizofrenia. Datos y cifras. Ginebra: OMS; 2025. Disponible en: https:// www.who.int/es/news-room/fact-sheets/detail/schizo-phrenia
5. Fonseca-Pedrero E, Lemos-Giráldez S. El síndrome psicó-tico: pasado, presente y futuro. En: Fonseca-Pedrero E (coord.). Tratamientos psicológicos para la psicosis. Madrid: Pirámide; 2019. p. 25-72.
6. Maguire M, Singh J, Marson A. Epilepsy and psychosis: a practical approach. Pract Neurol. 2018;18(2):106-14.
7. Han JW, Ahn YD, Kim WS, Shin CM, Jeong SJ, Song YS, et al. Psychiatric manifestation in patients with Parkinson's disease. J Korean Med Sci. 2018;33(47):e300.
8. Schneider RB, Iourinets J, Richard IH. Parkinson's disease psychosis: presentation, diagnosis and management. Neur Dis Manag. 2017;7(6):365-76.
9. Robles Bayón A, Gude Sampedro F. Síntomas conductuales y psiquiátricos en neurología cognitiva. Neurología. 2017;32(2):81-91.
10. Van der Linde RM, Dening T, Stephan BC, Prina AM, Evans E, Brayne C. Longitudinal course of behavioural and psychological symptoms of dementia: systematic review. Br J Psychiatry. 2016;209(5):366-77.
11. Hindley G, Beck K, Borgan F, Ginestet CE, McCutcheon R, Kleinloog D, et al. Psychiatric symptoms caused by canna-bis constituents: a systematic review and meta-analysis. Lancet Psychiatry. 2020;7(4):344-53.
12. Fonseca-Pedrero E, Lucas-Molina B, Pérez-Albéniz A, In-chausti F, Ortuño-Sierra J. Experiencias psicóticas atenua-das y consumo de cannabis en adolescentes de la población general. Adicciones. 2020;32(1):41-51.
13. VanderKruik R, Barreix M, Chou D, Allen T, Say L, Cohen LS; Maternal Morbidity Working Group. The global pre-valence of postpartum psychosis: a systematic review. BMC Psychiatry. 2017;17(1):272.
14. Forde R, Peters S, Wittkowski A. Psychological interven-tions for managing postpartum psychosis: a qualitative analysis of women's and family members' experiences and preferences. BMC Psychiatry. 2019;19(1):411.
15. Holford N, Channon S, Heron J, Jones I. The impact of postpartum psychosis on partners. BMC Pregnancy Child-birth. 2018;18(1):414.
16. González-Pando D, Alonso-Pérez F. Integrated care ‘schi-zophrenia’: a challenge for psychiatric/mental health nur-sing. En: Santos JC, Cutcliffe JR (eds.). European psychia-tric/mental health nursing in the 21st century. Cham: Springer International Publishing Switzerland; 2018.
p. 371-83.
17. Schalinski I, Breinlinger S, Hirt V, Teicher MH, Odenwald M, Rockstroh B. Environmental adversities and psychotic symptoms: the impact of timing of trauma, abuse, and ne-glect. Schizophr Res. 2019;205:4-9.
18. Franch Pato CM, Molina Rodríguez V, Franch Valverde JI. Síndrome metabólico y antipsicóticos atípicos: posibilidad de predicción y control. Rev Psiquiatr Salud Ment. 2017; 10(1):38-44.
19. Bobes T, González L, Alonso I, Morales R, Bobes J. Trata-miento combinado en la psicosis. En: Fonseca-Pedrero E (coord.). Tratamientos psicológicos para la psicosis. Madrid: Pirámide; 2019. p. 347-62.
20. Santos JC, Bashaw M, Mattcham W, Cutcliffe JR, Graziani
K. The biopsychosocial approach: towards holistic, person-centred psychiatric/mental health nursing practice. En: Santos JC, Cutcliffe JR (eds.). European psychiatric/men-tal health nursing in the 21st century. Cham: Springer In-ternational Publishing Switzerland; 2018. p. 89-103.
21. Ortuño J, Díez A, González-Pando D. Habilidades sociales: nuevas perspectivas y propuestas de intervención en psi-cosis. En: Fonseca-Pedrero E (coord.). Tratamientos psico-lógicos para la psicosis. Madrid: Pirámide; 2019. p. 285-315.
22. Jensen L, Clough R. Assessing and treating the patient with acute psychotic disorders. Nurs Clin North Am. 2016; 51(2):185-97.
23. Kennedy WZ, Mitzeliotis C. Esquizofrenia y otros trastor-nos psicóticos. En: O’Brien PG, Kennedy WZ, Ballard KA (eds.). Enfermería psiquiátrica. México: McGraw-Hill; 2001.
p. 295-320.
24. World Health Organization (WHO). ICD-11 for mortality and morbidity statistics. MB26.0 Delusion. Ginebra: WHO; 2020. Disponible en: https://icd.who.int/browse11/l-m/ es#/http://id.who.int/icd/entity/932028588
25. Fonseca-Pedrero E, Díez A, Pérez A. Evaluación del sín-drome psicótico. En: Fonseca Pedrero E (coord.). Trata-mientos psicológicos para la psicosis. Madrid: Pirámide; 2019. p. 79-100." "26. World Health Organization (WHO). ICD-11 for mortality and morbidity statistics. MB26.01 Delusion of being con-trolled. Ginebra: WHO; 2020. Disponible en: https://icd. who.int/browse11/l-m/es#/http://id.who.int/icd/enti-ty/1240694797
27. World Health Organization (WHO). ICD-11 for mortality and morbidity statistics. MB26.09 Somatic delusion. Gi-nebra: WHO; 2020. Disponible en: https://icd.who.int/ browse/2025-01/mms/en#1549775769
28. World Health Organization (WHO). ICD-11 for mortality and morbidity statistics. MB27.2 Hallucinations. Gine-bra: WHO; 2020. Disponible en: https://icd.who.int/ browse11/l-m/es#/http://id.who.int/icd/entity/66536 3966
29. World Health Organization (WHO). ICD-11 for mortality and morbidity statistics. 6D70 Delirium. Ginebra: WHO; 2020. Disponible en: https://icd.who.int/browse11/l m/ es#/http://id.who.int/icd/entity/897917531
30. Chouinard VA, Shinn AK, Valeri L, Chouinard PA, Gardner ME, Asan AE, et al. Visual hallucinations associated with multimodal hallucinations, suicide attempts and morbidity of illness in psychotic disorders. Schizophr Res. 2019;208: 196-201.
31. Mackinley M, Chan J, Ke H, Dempster K, Palaniyappan L. Linguistic determinants of formal thought disorder in first episode psychosis. Early Interv Psychiatry. 2021;15(2):344-51.
32. World Health Organization (WHO). ICD-11 for mortality and morbidity statistics. Catatonia. Ginebra: WHO; 2020. Disponible en: https://icd.who.int/browse11/l m/es#/ http://id.who.int/icd/entity/486722075
33. Walther S, Strik W. Catatonia. CNS Spectr. 2016;21(4): 341-8.
34. Cooper JJ, Ross DA. COVID-19 catatonia-would we even know? Biol Psychiatry. 2020;88(5):e19-21.
35. Huarcaya-Victoria J, Huete-Córdova M, Salirrosas-Alegría
C. Trombosis venosa profunda como complicación médica en un paciente con catatonia. Rev Neuropsiquiatr. 2016; 79(1):52-8.
36. Marder SR, Galderisi S. The current conceptualization of negative symptoms in schizophrenia. World Psychiatry. 2017;16(1):14-24.
37. González-Pando D, Alonso-Pérez F, Suárez-Gil P, García-Montes JM, Pérez-Álvarez M. Diminished emotional ex-pression in schizophrenia: an interdisciplinary approach based on behavioral interventions. Psicothema. 2018; 30(1):8-13.
38. Candida M, Campos C, Monteiro B, Rocha NBF, Paes F, Nardi AE, et al. Cognitive-behavioral therapy for schizo-phrenia: an overview on efficacy, recent trends and neu-robiological findings. Med Express. 2016;3(5):M160501.
39. Organización Mundial de la Salud. Guía de intervención mhGAP para los trastornos mentales, neurológicos y por consumo de sustancias en el nivel de atención de salud no especializada [Internet]. Ginebra: OMS; 2017 [citado 17 mar 2026]. Disponible en: https://iris.paho.org/items/ 732dc5f7-fbc2-48eb-8022-1aecbfe99daa
40. Bellido G, Senín C, Rodríguez JF, Perona S. Terapia cogni-tivo-conductual de los síntomas psicóticos positivos. En: Fonseca-Pedrero E (coord.). Tratamientos psicológicos para la psicosis. Madrid: Pirámide; 2019. p. 181-209.
41. Fonseca-Pedrero E, Pérez-Álvarez M, Al-Halabí S, Inchaus-ti F, Muñiz J, López-Navarro E, et al. Tratamientos psicoló-gicos empíricamente apoyados para adultos: una revisión selectiva. Psicothema. 2021;33(2):188-97.
42. Fumero A, Marrero RJ, De Miguel A, Peñate W. Interven-ciones psicoeducativas en psicosis. En: Fonseca-Pedrero E (coord.). Tratamientos psicológicos para la psicosis. Ma-drid: Pirámide; 2019. p. 255-79.
43. Gutiérrez JA. Plan de cuidados para la persona que sufre alucinaciones. En: Fornés J (ed.). Enfermería de salud men-tal y psiquiátrica: valoración y cuidados. 2.ª ed. Madrid: Editorial Médica Panamericana; 2012. p. 209-24.
44. Inchausti F, Sánchez-Reales S, Prado-Abril J. Proceso psi-coterapéutico en los trastornos del espectro psicótico. En: Fonseca-Pedrero E (coord.). Tratamientos psicológicos para la psicosis. Madrid: Pirámide; 2019. p. 145-74." "45. Ford K, Watson F. Mental health: working with people who hear voices. Br J Nurs. 2019;28(19):1242-4.
46. Gutiérrez JA. Plan de cuidados para la persona con ideas delirantes. En: Fornés J (ed.). Enfermería de salud mental y psiquiátrica: valoración y cuidados. 2.ª ed. Madrid: Edito-rial Médica Panamericana; 2012. p. 189-208.
47. Diagnósticos NANDA. 00122 Alteración de la percepción sensorial. Diagnosticosnanda.com; 2020. Disponible en: https://www.diagnosticosnanda.com/percepcion-cogni-cion/alteracion-de-la-percepcion-sensorial
48. Diagnósticos NANDA. 00130 Trastorno de los procesos de pensamiento. Diagnosticosnanda.com; 2020. Disponi-ble en: https://diagnosticosnanda.com/trastorno-de-los-procesos-de-pensamiento/
49. Zago MC, Menegazzo Padilha B. Atividade física como adjunto terapêutico para pacientes psiquiátricos com adoecimento mental severo: revisão da literatura. Psicol ver (Belo Horizonte). 2017;23(2):609-25.
50. Diagnósticos NANDA. 00053 Aislamiento social. Diagnos-ticosnanda.com; 2020. Disponible en: https://www.diag-nosticosnanda.com/aislamiento-social/
